Navigation Links
Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
Date:6/26/2008

BOSTON, June 26 /PRNewswire-USNewswire/ -- Headache specialists meet today in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.

For additional information, contact: Gina Czark at 312.558.1770, ext. 139 or gczark@pcipr.com or visit http://www.headachenews.org.

Among the topics being presented, include:

-- WHY PAIN BECOMES CHRONIC: Research shows previously unknown role certain

brain cells play in triggering chronic headaches for 9 million Americans

Think that pain medication is helping you ease the throbbing of a

headache? Think again. Researchers discovered neurons are not the only

carrier of pain signals to the brain. Glial cells, which outnumber

neurons 20:1, have been shown to prompt chronic pain in a variety of

ways, such as by a virus, nerve damage or even medication. Morphine and

other opiates also activate glial cells, which mean those drugs

you're taking to alleviate pain might actually be making it worse.

-- FIRST RIGOROUS TEST OF MAGNETIC STIMULATION DEVICE SHOWS PROMISE FOR

SHORT-CIRCUITING MIGRAINES: Research shows 7 million Americans could

benefit from this treatment

Imagine simply zapping away the pain at the onset of a migraine, instead

of gulping medication and waiting for relief. Researchers are presenting

encouraging results showing a portable transcranial magnetic stimulation

device would help an estimated 39 percent of migraine sufferers. The

device, about the size and weight of a hairdryer, works by placing it to

the back of the head and pushing a button twice, sending a very brief

magnetic field pulse into the brain. The 16-site multicenter,

randomized, double blind study is the first rigorous test of the

magnetic stimulation device.

-- STIMULATING THERAPY THAT HITS A NERVE: Early Research Shows New

Implanted Device Helps Alleviate Near-Daily Migraines

Stimulating a nerve might be just the ticket to help relieve the pain of

chronic migraine sufferers. Occipital nerve stimulation, in which an

implanted neurostimulator sends electrical impulses to the central

nervous system, has been shown to help 40 percent of near-daily migraine

sufferers who don't have success with standard pain medication.

Stimulating the occipital nerve, which ignites a tingling sensation,

appears to activate mechanisms that block the perception of pain in the

brain.


'/>"/>
SOURCE American Headache Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
2. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
3. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
4. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
7. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
8. Leading Immunologists Convene in Boston
9. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
10. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
11. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
(Date:2/24/2017)... CUPERTINO, Calif. , Feb. 24, 2017  In ... fourth quarter 2016 financial results press release, you are ... be broadcast live over the internet on Tuesday, March ... Pacific Time). A live audio webcast of ... at www.durect.com and clicking "Investor Relations."  If ...
(Date:2/24/2017)... NEW YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities ... New York City , announces that a ... of Massachusetts  against Inotek Pharmaceuticals ... purchasers of the Company,s securities between July 23, 2015 and ...
Breaking Medicine Technology:
(Date:2/24/2017)... IL (PRWEB) , ... February 24, 2017 , ... The ... the 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. ... Choice will be showcased and the winner revealed at the 31st annual iaedp Symposium, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
Breaking Medicine News(10 mins):